Search

Reading Time: 3 minutesThis blog was authored by Anne Marie Mercurio. Anne Marie is a Patient Advocate and a member of Medidata’s Patient Insights Board. As a Patient Advocate involved in gathering and sharing information through discussions, webinars, and conferences, I often hear quotes that are “Aha!” moments. One of those moments occurred recently when I heard Dr. […]

Article

Reading Time: 3 minutes Medidata’s annual event series—NEXT Global—brought together leaders from across the life sciences industry, including representatives from Moderna, Merck, AbbVie, and more to discuss innovative ways to foster patient engagement in clinical trials. We’ve compiled highlights of these discussions below, including the evolution of patient-first solutions, methods to drive engagement in minority communities and diversity in […]

Article

Reading Time: 3 minutesThe Mayo Score has been a long-established assessment tool within clinical trials designed to measure the severity of ulcerative colitis (UC). There is currently no known cure for UC, and patients that suffer from ulcerative colitis are often faced with managing a chronic condition that includes a number of symptoms, including abdominal pain, diarrhea, weight […]

Article

Reading Time: 3 minutesThis blog was authored by Fiona Maini, Global Compliance and Strategy Principal, and Valeria Orlova, Global Compliance and Strategy Analyst. In our ever-evolving world, we take many digital simplifications to traditional processes for granted. Our perception of the norm is shifting towards a reality where everyday activities are supported by technology. Signatures are no exception […]

Article

Reading Time: 2 minutesThe landscape of clinical trials has changed significantly in the last 24 months. Companies are now transitioning to take full advantage of the innovations born out of necessity during the pandemic. It’s clear that a risk-based approach to trial execution is paramount to ensuring success in the new clinical trial environment. A recent Association of […]

Article

Reading Time: 3 minutes This blog was authored by Mieke Whaley, Director, EMEA People and Business Partners at Medidata. If there’s one thing that two years of lockdowns, restrictions, and hybrid working have taught us, it’s that people need human connection. We need to feel connected to our colleagues, our employers, and our workplaces. In the early stages of […]

Article

Reading Time: 2 minutesMedidata AI is committed to consistently redefining how collaborative clinical trial data, technology, and expertise can improve patient lives and inspire the next generation of treatments. We’re excited to announce that two Medidata AI posters were accepted to present at the annual conference for the National Comprehensive Cancer Network (NCCN) 2022. These posters cover cutting-edge […]

Article

Reading Time: 3 minutesThe use of medical imaging in clinical research is becoming more common, with a growing number of indications over the past few years. Yet, managing medical images is complex, leading to significant quality challenges and trial delays if not performed correctly. Below is a depiction of the typical lifecycle of a medical imaging trial. The […]

Article

Reading Time: 3 minutesThe Clinical Financial Blog series was created to address the complexities that are encountered with the financial management of clinical trials. With a lot of critical financial requirements still not fully understood and addressed, we’ve got you covered. Medidata’s team of experts, who have lived and breathed the budgeting and site payments processes, will provide […]

Article

Reading Time: 5 minutesThis blog was authored by Fiona Maini, Global Compliance and Strategy Principal, Medidata. On January 28th, 2022, the UK Medicines & Healthcare products Regulatory Agency (MHRA) published guidance on clinical trials regarding risk-adapted approaches, risk assessments, oversight, and monitoring activities in two individual documents: Risk-adapted Approach to Clinical Trials and Risk Assessments1 and Oversight and Monitoring […]

Article

Reading Time: 4 minutesClinical trial data management is difficult even in the most well-designed and executed trials. Common issues, such as redundant clinical trial data entry, lack of integration between systems, and inconsistencies in trial design, plague most data collection methods. Your Electronic Data Capture (EDC) system providers should always be improving your EDC system so that all […]

Article

Reading Time: 3 minutesAt least one protocol amendment occurs in over half of all clinical trials according to Tufts Center for the Study of Drug Development (Tufts CSDD) research.1 Those amendments can disrupt sites and study teams, creating obstacles to efficiency. For example, sites may need to re-consent a patient if a change impacts how treatment will be delivered […]

Article